TWO SIGMA SECURITIES, LLC
Broker-DealerPosition in APUS — Apimeds Pharmaceuticals US, Inc.
CIK 1450144
NEW YORK, NY
Position in APUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,873
New position
Shares Held
10,550
first reported quarter
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 6 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA SECURITIES, LLC holds $1,408,992 across 13 Drug Manufacturers - Specialty & Generic names. APUS ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
510 | $302,419 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
10,720 | $256,529 | |
| 3 | SBFM |
Sunshine Biopharma Inc.
|
23,482 | $244,212 | |
| 4 | LQDA |
Liquidia Corp
|
5,496 | $207,419 | |
| 5 | CGC |
Canopy Growth Corp
|
99,372 | $94,304 | |
| 6 | SCYX |
Scynexis Inc
|
12,300 | $90,232 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
18,770 | $77,895 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
27,909 | $76,470 |
All Filings in APUS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,873 | 10,550 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||